Gsk (GSK) Equity Ratio (2016 - 2025)

Gsk has reported Equity Ratio over the past 12 years, most recently at 0.27 for Q4 2025.

For Q4 2025, Equity Ratio rose 16.55% year-over-year to 0.27; the TTM value through Dec 2025 reached 0.27, up 16.55%, while the annual FY2025 figure was 0.27, 16.55% up from the prior year.
Equity Ratio for Q4 2025 was 0.27 at Gsk, up from 0.23 in the prior quarter.
Over five years, Equity Ratio peaked at 0.27 in Q4 2025 and troughed at 0.18 in Q4 2022.
A 5-year average of 0.22 and a median of 0.23 in 2023 define the central range for Equity Ratio.
Biggest five-year swings in Equity Ratio: fell 7.42% in 2022 and later increased 28.37% in 2023.
Year by year, Equity Ratio stood at 0.19 in 2021, then fell by 7.42% to 0.18 in 2022, then increased by 28.37% to 0.23 in 2023, then rose by 1.64% to 0.23 in 2024, then grew by 16.55% to 0.27 in 2025.
Business Quant data shows Equity Ratio for GSK at 0.27 in Q4 2025, 0.23 in Q4 2024, and 0.23 in Q4 2023.

Peer Comparison